We have clarified that C1QBP promotes RCC cell hypoxanthine catabolism via up-regulating XDH, and apoptosis by modulating XDH mediated ROS generation and pro-apoptotic proteins caspase-3 and bax/bcl2, then affects tumor progression. The gene discussed is C1QBP; the disease is neoplasm.